ࡱ >
\ p None B a = c @ = Z ?N*8 X" 1 Arial1 Arial1 Arial1 Arial1 Arial1 Arial1 Arial General ` Table 2 r g Total (n = 368) Prior to SOP (n = 278) After SOP (n = 90) P Age, median (IQR), y
7 2 ( 6 0 7 9 ) 7 1 ( 6 0 7 8 )
7 6 ( 6 2 8 0 ) 0.049 Medical comorbidities Hyperlipidemia 196 (55%) 165 (60%) 31 (37%) <0.001 Hypertension 297 (82%) 229 (82%) 68 (79%) 0.524 Diabetes mellitus 90 (25%) 69 (25%) 21 (25%) 1 Smoking 70 (35%) 48 (41%) 22 (26%) 0.036 PAD 25 (7%) 20 (7%) 5 (6%) Obesity 126 (45%) 108 (55%) 18 (21%)$ Clinical scores, median (IQR) Admission NIHSS, median (IQR)
1 6 ( 1 1 2 1 )
1 7 ( 1 1 2 2 )
1 6 ( 1 1 2 0 ) 0.204 Admission mRS, median (IQR) 5 ( 4 5 ) 0.306 Discharge NIHSS, median (IQR) 9 ( 3 1 7 ) 9 ( 4 1 8 ) 7 ( 2 1 5 ) 0.043 Discharge mRS, median (IQR) 4 ( 2 5 ) 4 ( 1 . 5 5 ) 0.085# Imaging scores, median (IQR)
CT ASPECTS 8 ( 7 9 ) 0.883 CTA ASPECTS 7 ( 5 8 ) 7 ( 6 8 ) 0.247 CBV ASPECTS 6 ( 5 8 ) 0.011! S u c c e s s f u l R e p e r f u s i o n ( m T I C I e"2 b ) 191 (55%) 132 (51%) 59 (66%) 0.019 Occlusion sites 0.316 proximal ICA 11 (3%) 10 (4%) 1 (1%) Carotid-T 51 (14%) 43 (16%) 8 (9%) M1 206 (56%) 151 (54%) 55 (61%) M2 27 (7%) 18 (6%) 9 (10%) BA 71 (19%) 54 (19%) 17 (19%) PCA 2 (1%) 0 Administration of rtPA 244 (66%) 176 (64%)
68 (75,6%) 0.053
d MbP?_ % * + &P &F